Could a Baby-Friendly ivermectin formula beat scabies?

NCT ID NCT06918665

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This trial compares a new ivermectin powder mixed with infant formula to the standard tablet in 52 healthy adults. The goal is to see if the new formulation is absorbed similarly, tastes better, and causes no new side effects. Results will guide future use in children with scabies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ivermectin

What this could lead to

If successful, this could lead to a more palatable ivermectin formulation for children, making scabies treatment easier.

What could go wrong

This is a small, early-phase trial in healthy adults, not children. The new formulation may not prove bioequivalent or could have unexpected side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCABIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

scabies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Royal Children's Hospital

    Melbourne, Victoria, 3016, Australia